Ayurvedic Drug AYUSH 64 Effective in Asymptomatic, Mild Covid-19 Cases: Ministry

The Ministry of Ayush on Thursday said AYUSH 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences, has been found to be effective in treatment of of mild to moderate cases of COVID-19 infection. Dr Arvind Chopra, Director, Centre for Rheumatic Diseases, Pune and honorary chief clinical coordinator of the Ministry of Ayush – CSIR collaboration informed that The trial of AYUSH 64 was conducted at three centres — KGMU in Lucknow, DMIMS in Wardha and BMC COVID Centre in Mumbai — and involved 70 participants in each arm, said Dr Arvind Chopra, Director, chief clinical coordinator of the Ministry of Ayush- CSIR collaboration. The multi-centre trial of AYUSH 64 was monitored by Ayush-CSIR Joint Monitoring Committee, Department of Health Research and former Director General, Indian Council of Medical Research, said Dr Bhushan Patwardhan, National Research Professor, Ayush. “It is worthwhile to note that this committee has also recommended Ministry to communicate to the state licensing authorities/regulators regarding adding new indication of AYUSH 64 for repurposing in the management of mild to moderate COVID-19,” said Dr. V M Katoch, Chairman of the MC. “Additional studies on Ayush 64 are underway at reputed research institutes including CSIR-IIIM, DBT-THSTI, ICMR-NIN, AIIMS Jodhpur and Medical Colleges including Post Graduate Institute of Medical Education & Research, Chandigarh; King George’s Medical University, Lucknow; Government Medical College, Nagpur; Datta Meghe Institute of Medical Sciences, Nagpur,” the Ministry statement quoted Dr N Srikanth, Director General, CCRAS.